PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $24,000 | -71.8% | 9,898 | -73.4% | 0.02% | -67.1% |
| Q1 2017 | $85,000 | -69.0% | 37,230 | -71.2% | 0.07% | -38.1% |
| Q4 2016 | $274,000 | +15.6% | 129,480 | +83.3% | 0.11% | -28.5% |
| Q3 2016 | $237,000 | +15.6% | 70,622 | +8.1% | 0.16% | +3.9% |
| Q2 2016 | $205,000 | -32.3% | 65,341 | -28.3% | 0.15% | -27.6% |
| Q1 2016 | $303,000 | – | 91,141 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAYS ADVISORY LLC | 1,037,600 | $6,672,000 | 0.97% |
| Global X Management CO LLC | 2,435,411 | $15,660,000 | 0.86% |
| Advisors Asset Management, Inc. | 5,373,113 | $34,549,000 | 0.47% |
| Gotham Asset Management, LLC | 7,233,838 | $46,514,000 | 0.39% |
| TFS CAPITAL LLC | 582,438 | $3,745,000 | 0.37% |
| LOMBARDIA CAPITAL PARTNERS LLC | 1,637,611 | $10,530,000 | 0.36% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 95,122 | $611,634,000 | 0.33% |
| FIRST TRUST ADVISORS LP | 17,536,793 | $112,762,000 | 0.29% |
| Arrow Investment Advisors, LLC | 214,595 | $1,380,000 | 0.28% |
| GSA CAPITAL PARTNERS LLP | 954,853 | $6,140,000 | 0.24% |